在炎症性肠病中选择细胞因子和金属蛋白酶
Barbara Sosna1, David Aebisher2, Angelika Myśliwiec3
1Department of Internal Medicine, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Batorego 15 Street, 41-902 Bytom, Poland.
International journal of molecular sciences
|January 11, 2024
概括
炎症性肠道疾病 (IBD),包括性结肠炎和克罗恩病,涉及细胞因子和矩阵金属蛋白酶 (MMP) 的增加. 它们在炎症组织中的过度产生对IBD病原发生有显著的贡献.
科学领域:
- 免疫学和胃肠道学
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 炎症性肠病 (IBD) 包括性结肠炎 (UC) 和克罗恩病 (CD),受遗传,环境和免疫因素的影响.
- 细胞外矩阵金属蛋白酶 (MMPs) 是IBD的新兴指标.
- 转录组研究正在加强炎症IBD组织中细胞因子微环境的表征.
研究的目的:
- 审查特定细胞因子和矩阵金属蛋白酶 (MMP) 在IBD病变发生过程中的作用.
- 综合目前对免疫系统参与IBD病理生理学的理解.
- 突出MMP及其抑制剂在IBD中的重要性.
主要方法:
- 基于选择性的PubMed搜索的文献评论.
- 包括系统审查,元分析和临床试验.
- 专注于研究"炎症性肠病"和"炎症性肠病的发病".
主要成果:
- 在UC和CD的炎症组织中观察到几个细胞因子的持续升高水平.
- 在炎症过程,癌症和IBD的病理学中,MMPs起着至关重要的作用.
- 与IBD相关的炎症包括增加MMP表达和减少组织金属蛋白酶抑制剂 (TIMPs) 的抑制.
结论:
- 在炎症IBD组织中,MMPs的过度产生和TIMP活动不足有助于疾病病理.
- 细胞因子和MMP是免疫系统参与IBD病理生理学的关键参与者.
- 对这些分子机制的进一步研究对于理解和潜在的治疗IBD至关重要.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
248
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
248
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
187
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
187
01:29Drugs for Treatment of Ulcerative Colitis in IBD
142
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
142